EXPRESSION OF HLA-D SUBLOCI DR AND DQ BY BREAST CARCINOMAS IS CORRELATED WITH DISTINCT PARAMETERS OF FAVORABLE PROGNOSIS

被引:37
作者
BRUNNER, CA [1 ]
GOKEL, JM [1 ]
RIETHMULLER, G [1 ]
JOHNSON, JP [1 ]
机构
[1] UNIV MUNICH,INST IMMUNOL,GOETHESTR 31,W-8000 MUNICH 2,GERMANY
关键词
D O I
10.1016/0277-5379(91)90374-M
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of HLA-D region products HLA-DR, DQ and DP by primary breast carcinomas was examined for its relationship to standard prognostic parameters. A positive correlation was found between the expression of HLA-DR and the differentiation state of the tumour (P = 0.02) and the expression of progesterone receptors (P = 0.002), two parameters which are associated with good prognosis and with each other. No correlation was seen between these parameters and the expression of HLA-DQ or HLA-DP. In contrast, tumour diameter was inversely correlated with the expression of HLA-DQ (P = 0.0004) although no association was observed between this parameter and HLA-DR expression. Essentially all HLA-DQ positive tumours had a diameter of less than 2 cm although these represented only 50% of the tumours of this size examined. These data show that in breast carcinomas HLA class II expression is correlated with several distinct parameters of good prognosis and suggest that HLA-DQ expression may define a subtype of T1 tumours.
引用
收藏
页码:411 / 416
页数:6
相关论文
共 41 条
[1]   ANALYSIS OF ANTIGEN PRESENTATION USING HLA TRANSFECTANTS [J].
ALTMANN, DM ;
WILKINSON, D ;
IKEDA, H ;
TROWSDALE, J .
IMMUNOLOGIC RESEARCH, 1990, 9 (01) :57-68
[2]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[3]   H-2-CONTROLLED SUPPRESSION OF T-CELL RESPONSE TO LACTATE DEHYDROGENASE-B - CHARACTERIZATION OF THE LACTATE DEHYDROGENASE-B SUPPRESSOR PATHWAY [J].
BAXEVANIS, CN ;
ISHII, N ;
NAGY, ZA ;
KLEIN, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (03) :822-833
[4]  
BERNARD DJ, 1980, ANTICANCER RES, V6, P79
[5]  
BIRKBY CA, 1988, J CELL SCI, V89, P167
[6]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[7]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545
[8]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[9]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[10]   CHARACTERIZATION AND EXPRESSION OF THE HLA-DC ANTIGENS DEFINED BY ANTI-LEU 10 [J].
CHEN, YX ;
EVANS, RL ;
POLLACK, MS ;
LANIER, LL ;
PHILLIPS, JH ;
ROUSSO, C ;
WARNER, NL ;
BRODSKY, FM .
HUMAN IMMUNOLOGY, 1984, 10 (04) :221-235